MEDICINOVA, INC. Payments to Acquire Interest in Joint Venture
MEDICINOVA, INC. (MNOV) reported Payments to Acquire Interest in Joint Venture of $680.00 thousand for the 156-month period ending 2013-09-30, per its 10-Q filed 2013-11-07.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInterestInJointVenture · last filed 2014-03-27
- MEDICINOVA, INC. payments to acquire interest in joint venture for the quarter ending 2013-09-30 was $0.00.
- MEDICINOVA, INC. payments to acquire interest in joint venture for the quarter ending 2013-06-30 was $0.00.
- MEDICINOVA, INC. payments to acquire interest in joint venture for the quarter ending 2013-03-31 was $0.00, a 100.00% decline year-over-year.
- MEDICINOVA, INC. payments to acquire interest in joint venture for the quarter ending 2012-12-31 was $0.00.
- MEDICINOVA, INC. payments to acquire interest in joint venture for fiscal 2012 was $680.00K.
| Period end | Payments to Acquire Interest in Joint Venture 1 month | Payments to Acquire Interest in Joint Venture 3 month | Payments to Acquire Interest in Joint Venture 6 month | Payments to Acquire Interest in Joint Venture 9 month | Payments to Acquire Interest in Joint Venture 12 month | Payments to Acquire Interest in Joint Venture 138 month | Payments to Acquire Interest in Joint Venture 141 month | Payments to Acquire Interest in Joint Venture 144 month | Payments to Acquire Interest in Joint Venture 147 month | Payments to Acquire Interest in Joint Venture 150 month | Payments to Acquire Interest in Joint Venture 153 month | Payments to Acquire Interest in Joint Venture 156 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-09-30 | $0.00 derived: 10-Q 156 month − 10-Q 153 month · filed 2013-11-07 | $0.00 derived: sum of 2 quarters · filed 2013-11-07 | $0.00 derived: sum of 3 quarters · filed 2013-11-07 | $0.00 derived: sum of 4 quarters · filed 2014-03-27 | $680.00K 10-Q · filed 2013-11-07 | |||||||
| 2013-06-30 | $0.00 derived: 10-Q 153 month − 10-Q 150 month · filed 2013-08-08 | $0.00 derived: sum of 2 quarters · filed 2013-08-08 | $0.00 derived: sum of 3 quarters · filed 2014-03-27 | $0.00 derived: sum of 4 quarters · filed 2014-03-27 | $680.00K 10-Q · filed 2013-08-08 | |||||||
| 2013-03-31 | $0.00 derived: 10-Q 150 month − 10-K 147 month · filed 2013-05-08 | $0.00 derived: sum of 2 quarters · filed 2014-03-27 | $0.00 derived: sum of 3 quarters · filed 2014-03-27 | $0.00 derived: sum of 4 quarters · filed 2014-03-27 | $680.00K 10-Q · filed 2013-05-08 | |||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $0.00 derived: sum of 2 quarters · filed 2014-03-27 | $0.00 derived: sum of 3 quarters · filed 2014-03-27 | $680.00K 10-K · filed 2014-03-27 | $680.00K 10-K · filed 2013-03-28 | |||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $0.00 derived: sum of 2 quarters · filed 2013-11-07 | $680.00K 10-Q · filed 2013-11-07 | $680.00K 10-Q · filed 2012-11-08 | ||||||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $680.00K 10-Q · filed 2013-08-08 | $680.00K 10-Q · filed 2012-08-09 | |||||||||
| 2012-03-31 | $680.00K 10-Q · filed 2013-11-07 | $680.00K 10-Q · filed 2013-05-08 | $680.00K 10-Q · filed 2012-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |